These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37671867)

  • 1. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    Hsieh SH; Yu FH; Huang KJ; Wang CT
    J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production.
    Chiang CC; Wang SM; Tseng YT; Huang KJ; Wang CT
    Virology; 2009 Jan; 383(2):261-70. PubMed ID: 19019404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.
    Chiang CC; Wang SM; Pan YY; Huang KJ; Wang CT
    J Virol; 2010 Jan; 84(2):976-82. PubMed ID: 19889767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.
    Sudo S; Haraguchi H; Hirai Y; Gatanaga H; Sakuragi J; Momose F; Morikawa Y
    J Virol; 2013 Mar; 87(6):3348-60. PubMed ID: 23302874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional activation of an HIV-1 protease attenuated mutant by a leucine zipper dimerization motif.
    Yu FH; Huang KJ; Wang CT
    Virus Res; 2021 Apr; 295():198258. PubMed ID: 33316353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
    Olivares I; Mulky A; Boross PI; Tözsér J; Kappes JC; López-Galíndez C; Menéndez-Arias L
    J Mol Biol; 2007 Sep; 372(2):369-81. PubMed ID: 17651754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.
    Chiang CC; Tseng YT; Huang KJ; Pan YY; Wang CT
    Virology; 2012 Jan; 422(2):278-87. PubMed ID: 22104208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.
    Pan YY; Wang SM; Huang KJ; Chiang CC; Wang CT
    PLoS One; 2012; 7(3):e32845. PubMed ID: 22396796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between protease and reverse transcriptase dimerization in a model HIV-1 polyprotein.
    Chagas BCA; Zhou X; Guerrero M; Ilina TV; Ishima R
    Protein Sci; 2024 Jul; 33(7):e5080. PubMed ID: 38896002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
    Yu FH; Huang KJ; Wang CT
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31906562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
    Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
    J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME; Parniak MA
    J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.
    Popov S; Strack B; Sanchez-Merino V; Popova E; Rosin H; Göttlinger HG
    J Virol; 2011 Apr; 85(8):3792-801. PubMed ID: 21289110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package.
    Lin YR; Chu SM; Yu FH; Huang KJ; Wang CT
    BMC Microbiol; 2022 Apr; 22(1):94. PubMed ID: 35395730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
    Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
    FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
    Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
    J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation.
    Tachedjian G; Moore KL; Goff SP; Sluis-Cremer N
    FEBS Lett; 2005 Jan; 579(2):379-84. PubMed ID: 15642347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.